FR2553662B1 - Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sang - Google Patents
Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sangInfo
- Publication number
- FR2553662B1 FR2553662B1 FR8416171A FR8416171A FR2553662B1 FR 2553662 B1 FR2553662 B1 FR 2553662B1 FR 8416171 A FR8416171 A FR 8416171A FR 8416171 A FR8416171 A FR 8416171A FR 2553662 B1 FR2553662 B1 FR 2553662B1
- Authority
- FR
- France
- Prior art keywords
- triglycerides
- composition
- rate
- reduce
- fatty acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003626 triacylglycerols Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
- C11C1/025—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by saponification and release of fatty acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0056—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/005—Splitting up mixtures of fatty acids into their constituents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Edible Oils And Fats (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54535083A | 1983-10-24 | 1983-10-24 | |
US06/545,349 US4526902A (en) | 1983-10-24 | 1983-10-24 | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2553662A1 FR2553662A1 (fr) | 1985-04-26 |
FR2553662B1 true FR2553662B1 (fr) | 1989-06-09 |
Family
ID=27067902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8416171A Expired FR2553662B1 (fr) | 1983-10-24 | 1984-10-23 | Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sang |
Country Status (7)
Country | Link |
---|---|
CA (1) | CA1239587A (fr) |
CH (1) | CH661209A5 (fr) |
DE (1) | DE3438630A1 (fr) |
FR (1) | FR2553662B1 (fr) |
GB (1) | GB2148713B (fr) |
IT (1) | IT1178170B (fr) |
SE (1) | SE462701B (fr) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8507058D0 (en) * | 1985-03-19 | 1985-04-24 | Efamol Ltd | Pharmaceutical & dietary compositions |
US4792418A (en) * | 1985-08-14 | 1988-12-20 | Century Laboratories, Inc. | Method of extraction and purification of polyunsaturated fatty acids from natural sources |
GB8601915D0 (en) * | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
DE3603000A1 (de) * | 1986-01-31 | 1987-08-06 | Milupa Ag | Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen |
DE3615710A1 (de) * | 1986-05-09 | 1987-11-26 | Hoechst Ag | Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen |
HU204199B (en) * | 1987-03-18 | 1991-12-30 | Caola Kozmetikai | Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components |
GB8715914D0 (en) * | 1987-07-07 | 1987-08-12 | Efamol Ltd | Treatment of cerabral disorders |
US4843095A (en) * | 1987-08-07 | 1989-06-27 | Century Laboratories, Inc. | Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis |
FR2623692B1 (fr) * | 1987-11-30 | 1991-05-03 | Vernin Jean Gilles | Nouvelle huile dietetique |
HU210122B (en) * | 1988-03-23 | 1995-02-28 | Biorex Kutato Fejlesztoe Kft | Process for production of composition against thromboembolytic conditions of circulating system and heart |
GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
US5116871A (en) * | 1988-09-13 | 1992-05-26 | Efamol Holdings Plc | Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis |
DK162621C (da) * | 1989-04-27 | 1992-04-13 | Jon Katborg | Skumformigt fedtstofprodukt og fremgangsmaade til fremstilling af samme |
DE3924607A1 (de) * | 1989-07-21 | 1991-01-24 | Singer Peter Dr Sc Med | Diaetetisches nahrungs- oder genussmittel |
DE19503993A1 (de) * | 1995-02-08 | 1996-08-14 | Johann Friedrich Dr Med Desaga | Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen |
EP1886679A3 (fr) * | 1995-06-07 | 2008-05-28 | Martek Biosciences Corporation | Procédés de contrôle de contenu d'acide gras hautement non saturés dans plusieurs tissus |
PT956013E (pt) | 1996-10-11 | 2003-08-29 | Scarista Ltd | Preparacao farmaceutica compreendendo acido eicosapentaenoico e/ou acido estearidonico |
DE19903095C2 (de) * | 1999-01-27 | 2003-05-22 | Nutrinova Gmbh | Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium |
GB9901809D0 (en) | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
SE0202188D0 (sv) | 2002-07-11 | 2002-07-11 | Pronova Biocare As | A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
EP2295529B2 (fr) | 2002-07-11 | 2022-05-18 | Basf As | Procédé de diminution des polluants environnementaux dans une huile ou une graisse et produit d'alimentation pour poissons |
US6846942B2 (en) | 2003-05-20 | 2005-01-25 | David Rubin | Method for preparing pure EPA and pure DHA |
ITMI20040069A1 (it) | 2004-01-21 | 2004-04-21 | Tiberio Bruzzese | Uso di composizioni di acidi grassi n-3 ad elevata concentrazione per il trattamento di disturbi del sistema nervoso centrale |
ES2281270B1 (es) | 2005-11-30 | 2008-07-01 | La Morella Nuts, S.A. | Alimento funcional con efectos positivos en la prevencion de enfermedades cardiovasculares. |
EP3578177A1 (fr) | 2008-09-02 | 2019-12-11 | Amarin Pharmaceuticals Ireland Limited | Composition pharmaceutique contenant de l'acide eicosapentaénoïque et leurs procédés d'utilisation |
PT2395991E (pt) | 2009-02-10 | 2013-09-03 | Amarin Pharmaceuticals Ie Ltd | Utilização de éster etílico de ácido eicosapentaenóico para tratamento de hipertrigliceridemia |
NZ627238A (en) | 2009-04-29 | 2016-02-26 | Amarin Pharmaceuticals Ie Ltd | Stable pharmaceutical composition comprising ethyl eicosapentaenoate |
NZ789295A (en) | 2009-04-29 | 2024-02-23 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
CN114053258A (zh) | 2009-06-15 | 2022-02-18 | 阿马里纳药物爱尔兰有限公司 | 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法 |
WO2011018096A1 (fr) * | 2009-08-10 | 2011-02-17 | K.D. Pharma Bexbach Gmbh | Procédé de fractionnement d'acide phytanique, produits d'acide gras et leur utilisation |
SG10201405994UA (en) | 2009-09-23 | 2014-10-30 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical Composition Comprising Omega-3 Fatty Acid And Hydroxy-derivative Of A Statin And Methods Of Using Same |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
NZ778131A (en) | 2010-11-29 | 2023-03-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
WO2013070735A1 (fr) | 2011-11-07 | 2013-05-16 | Amarin Pharmaceuticals Ireland Limited | Méthodes de traitement de l'hypertriglycéridémie |
AU2013207368A1 (en) | 2012-01-06 | 2014-07-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity (hs-CRP) in a subject |
JP2015522029A (ja) | 2012-06-29 | 2015-08-03 | アマリン ファーマシューティカルス アイルランド リミテッド | スタチン療法中の患者における心血管系イベントの危険性を減少させる方法 |
US20150265566A1 (en) | 2012-11-06 | 2015-09-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
WO2018213663A1 (fr) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions et méthodes pour dimunuer les triglycérides chez un sujet ayant une fonction rénale réduite |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
CN112218630A (zh) | 2018-09-24 | 2021-01-12 | 阿马里纳药物爱尔兰有限公司 | 降低受试者的心血管事件的风险的方法 |
WO2022225896A1 (fr) | 2021-04-21 | 2022-10-27 | Amarin Pharmaceuticals Ireland Limited | Procédés de réduction du risque d'insuffisance cardiaque |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1476624A (en) * | 1973-05-30 | 1977-06-16 | Cepbepe | Tranquiliser medicaments |
AU527784B2 (en) * | 1978-05-26 | 1983-03-24 | Bang, Hans Olaf Dr. | Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid |
GB2033745B (en) * | 1978-05-26 | 1983-08-17 | Wellcome Found | Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions |
GB1604554A (en) * | 1978-05-26 | 1981-12-09 | Dyerberg J | Pharmaceutical and food formulations |
DE3152174A1 (de) * | 1980-06-27 | 1982-08-12 | Nippon Oils & Fats Co Ltd | Thrombosis-prophylatic and curing agent |
US4377526A (en) * | 1981-05-15 | 1983-03-22 | Nippon Suisan Kaisha, Ltd. | Method of purifying eicosapentaenoic acid and its esters |
GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
FR2548021B1 (fr) * | 1983-06-29 | 1986-02-28 | Dick P R | Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels |
GB8319073D0 (en) * | 1983-07-14 | 1983-08-17 | Efamol Ltd | Fatty acid compositions |
-
1984
- 1984-10-16 CA CA000465531A patent/CA1239587A/fr not_active Expired
- 1984-10-22 DE DE19843438630 patent/DE3438630A1/de not_active Ceased
- 1984-10-23 GB GB08426765A patent/GB2148713B/en not_active Expired
- 1984-10-23 FR FR8416171A patent/FR2553662B1/fr not_active Expired
- 1984-10-23 CH CH5070/84A patent/CH661209A5/de not_active IP Right Cessation
- 1984-10-24 SE SE8405308A patent/SE462701B/sv not_active IP Right Cessation
- 1984-10-24 IT IT49063/84A patent/IT1178170B/it active
Also Published As
Publication number | Publication date |
---|---|
GB2148713B (en) | 1987-04-23 |
GB8426765D0 (en) | 1984-11-28 |
SE8405308L (sv) | 1985-04-25 |
IT1178170B (it) | 1987-09-09 |
FR2553662A1 (fr) | 1985-04-26 |
CH661209A5 (de) | 1987-07-15 |
IT8449063A1 (it) | 1986-04-24 |
DE3438630A1 (de) | 1985-05-02 |
SE8405308D0 (sv) | 1984-10-24 |
CA1239587A (fr) | 1988-07-26 |
GB2148713A (en) | 1985-06-05 |
SE462701B (sv) | 1990-08-20 |
IT8449063A0 (it) | 1984-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2553662B1 (fr) | Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sang | |
BE873599A (fr) | Catalyseurs pour l'oxydation du co en co2 et procede de preparation | |
FR2566394B1 (fr) | Procede pour la preparation d'esters des acides acrylique et methacrylique par trans-esterification | |
BE891211A (fr) | Preparation d'anhydride acetique | |
FR2566393B1 (fr) | Procede pour la preparation d'esters des acides acrylique et methacrylique par trans-esterification | |
PT78275A (fr) | Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant | |
IT8419141A0 (it) | Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina. | |
PT87017A (pt) | Process for the preparation of pharmaceutical compositions acting on the heart and cardiovascular system containing a mixture of selenium-containing algae and higher unsaturated fatty acids | |
FR2602229B1 (fr) | Procede de preparation d'esters d'acides carboxyliques insatures | |
EP0138491A3 (fr) | Acides 2(1H)-quinazolinone-1-alcanoiques substitués et esters | |
IT8222274A0 (it) | Esteri dell'acido 3-metilflavone-8-carbossilico. | |
FR2558372B1 (fr) | Composition medicamenteuse pour le traitement de l'acne | |
BE893324A (fr) | Preparation d'esters d'acides carboxyliques | |
BE891611A (fr) | Preparation d'anhydrides d'acides carboxyliques | |
BE893322A (fr) | Preparation d'acides carboxyliques | |
PT85278A (fr) | Procede de preparation d:une fraction immunogene active a liegard des bilharzioses et de compositions immunisantes la contenant | |
FR2549726B1 (fr) | Facteurs augmentant la formation d'anticorps humains et procede pour leur preparation | |
IT1157325B (it) | Esteri dell'acido antranilico | |
FR2535322B1 (fr) | Preparation d'acides aminocyclopentaniques | |
RO92794A (fr) | Procede pour la preparation des esters d'acide 2-brome-4-methylimdazole-5-carboxilique | |
BE893419A (fr) | Production d'acides carboxyliques et d'esters | |
FR2517542B1 (fr) | Medicament pour l'amelioration du metabolisme lipidique | |
RO86562A2 (fr) | Composition vegetale medicamenteuse pour le traitement des affectionsbiliares | |
IT1142034B (it) | Procedimento per la preparazione di esteri dell'acido | |
FR2511677B1 (fr) | Procede de preparation d'esters des acides alcoxyvincaminiques et alcoxyapovincaminiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |